BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/29/2019 2:00:23 AM | Browse: 1042 | Download: 1748
 |
Received |
|
2018-09-26 01:56 |
|
Peer-Review Started |
|
2018-09-26 09:59 |
|
To Make the First Decision |
|
2018-11-16 01:05 |
|
Return for Revision |
|
2018-11-29 01:05 |
|
Revised |
|
2018-12-04 00:32 |
|
Second Decision |
|
2018-12-21 08:51 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-12-21 19:58 |
|
Articles in Press |
|
2018-12-21 19:58 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-12-30 08:38 |
|
Typeset the Manuscript |
|
2019-01-23 06:05 |
|
Publish the Manuscript Online |
|
2019-01-29 02:00 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Case Report |
| Article Title |
Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hai-Di Wu, Hong-Yan Cao, Zi-Kai Song, Shuo Yang, Ming-Long Tang, Yang Liu and Ling Qin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ling Qin, MD, PhD, Professor, Department of Cardiology, First Hospital of Jilin University, 3302 Jilin Street, Changchun 130031, Jilin Province, China. qinling1958@163.com |
| Key Words |
Rivaroxaban; Routine coagulation monitoring; Anticoagulation; Bleeding; Case report |
| Core Tip |
Guidelines recommend that patients treated with non-vitamin K antagonist oral anticoagulants do not require coagulation monitoring and showed that routine coagulation tests generally do not provide an accurate assessment of effects and bleeding for rivaroxaban. However, our case indicates that in real-world situations, a small number of patients may develop changes in prothrombin time, international normalized ratio, and activated partial thromboplastin time with bleeding during rivaroxaban therapy. The results of literature review suggest that routine coagulation assays may be required in special population including elderly patients, particularly low-weight females or those with renal insufficiency during oral rivaroxaban. |
| Publish Date |
2019-01-29 02:00 |
| Citation |
Wu HD, Cao HY, Song ZK, Yang S, Tang ML, Liu Y, Qin L. Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature. World J Clin Cases 2019; 7(3): 382-388 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i3/382.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i3.382 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
